Altor BioScience
is a clinical-stage biopharmaceutical company that focuses on developing immunotherapies for the treatment of cancer and viral infections... Read moreAltor BioScience
is a clinical-stage biopharmaceutical company that focuses on developing immunotherapies for the treatment of cancer and viral infections... Read more
Founder & CEO
Hing C. Wong
News
Nov 08, 2022
Law 360
Altor BioScience: Attys Seek $1.65M Award For Altor-NantCell Deal In Del.
Oct 08, 2018
BioPortfolio
Altor BioScience: Altor BioScience Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Sep 12, 2018
BioPortfolio
Altor BioScience: Altor BioScience Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250
Apr 06, 2018
BioPortfolio
Altor BioScience: Articles ALT803 an IL15 superagonist in combination with nivolumab in patients with metastatic nonsmall cell lung cancer a nonrandomised openlabel phase 1b trial
Jan 03, 2018
BioPortfolio
Altor BioScience: Altor BioScience Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 20122017 Prices from USD $250
Oct 03, 2017
The Business Journals: Los Angeles Biz
Altor BioScience: Cher sues billionaire Patrick Soon-Shiong over alleged stock fraud
Aug 01, 2017
Sun Sentinel
Altor BioScience: Miramar cancer drug developer merges with California firm in deal exceeding $1 billion
Jul 29, 2017
BioPortfolio
Altor BioScience: Altor BioScience Corp Pharmaceuticals Healthcare Deals and Alliances Profile. Report Updated 20072017 Prices from USD $250
Jul 13, 2017
Healthcare IT News
Altor BioScience: Altor investors amend suit against Patrick Soon-Shiong, claim mogul paid off board members
Jun 27, 2017
FierceBiotechIT
Altor BioScience: Despite claims of 'looting,' Soon-Shiong's NantCell set to buy Altor
Altor BioScience Competitors
1
2
3
4
5
6
7
8
9
10